Generic selectors
Exact matches only
Search in title
Search in content
Post Type Selectors
post

Glenmark Life Sciences Ltd Financial Statements & Historical Data

Updated NSE: GLENMARKBSE: 532296
Report details
Last Updated:
Author: |Social: XLinkedIn
COMPANY FINANCIAL DATA

Reported figures at a glance

Stored figures, not live quotes. Price record: 8 October 2026, 6:22 pm +05:30. Financial reporting periods are shown in the tables below.

Stored share price2,210₹ per share
Reported P/E20.0Times
Book value per share372₹ per share
Reported ROCE39.8 %%
Data sources and reporting basis

Sources: Company data source. Check the company filings linked by the source for the reporting basis and exceptional items.

Different tables can have different reporting dates and accounting bases. Verify the company filings before comparing figures. Missing data is not treated as zero.

How Getaka handles sources, dates and corrections. Page revision dates describe the page, not the age of every financial figure.

Financial changes explained

Automatically calculated historical comparisons. Amounts are in ₹ crore unless stated otherwise. These summaries describe reported figures and do not rate or recommend the shares.

Reporting coverage: Quarterly: Jun 2026 · Annual: Mar 2026 · Cash flow: Mar 2026 · Balance sheet: Mar 2026.

Quarterly revenue change

Quarterly revenue was ₹4,018.00 crore in Jun 2026, compared with ₹3,264.00 crore in Jun 2025. The change was an increase of ₹754.00 crore. Year-on-year change: +23.1%.

Calculation and source

Absolute change = later amount − earlier amount. Percentage change = (later ÷ earlier − 1) × 100.

Basis: consolidated. Period: 2025-06 to 2026-06.

View the financial table · Data source

Quarterly net result change

Quarterly net result was ₹483.00 crore in Jun 2026, compared with ₹47.00 crore in Jun 2025. The change was an increase of ₹436.00 crore. Year-on-year change: +927.7%.

Calculation and source

Absolute change = later amount − earlier amount. Percentage change = (later ÷ earlier − 1) × 100.

Basis: consolidated. Period: 2025-06 to 2026-06.

View the financial table · Data source

Annual revenue change

Annual revenue was ₹16,983.00 crore in Mar 2026, compared with ₹13,322.00 crore in Mar 2025. The change was an increase of ₹3,661.00 crore. Year-on-year change: +27.5%.

Calculation and source

Absolute change = later amount − earlier amount. Percentage change = (later ÷ earlier − 1) × 100.

Basis: consolidated. Period: 2025-03 to 2026-03.

View the financial table · Data source

Annual net result change

Annual net result was ₹1,362.00 crore in Mar 2026, compared with ₹1,047.00 crore in Mar 2025. The change was an increase of ₹315.00 crore. Year-on-year change: +30.1%.

Calculation and source

Absolute change = later amount − earlier amount. Percentage change = (later ÷ earlier − 1) × 100.

Basis: consolidated. Period: 2025-03 to 2026-03.

View the financial table · Data source

Quarterly net profit margin

Calculated net profit margin moved from 1.44% in Jun 2025 to 12.02% in Jun 2026: 10.58 percentage points higher.

Calculation and source

Margin = net profit ÷ revenue × 100. Margin change is measured in percentage points; rounded source figures can affect the result.

Basis: consolidated. Period: 2025-06 to 2026-06.

View the financial table · Data source

Eight-quarter revenue comparison

Revenue across the four quarters ending Jun 2026 totalled ₹17,737.00 crore, compared with ₹13,342.00 crore across the preceding four quarters. The change was 32.9%.

Calculation and source

Sum four consecutive quarters and compare with the preceding four non-overlapping quarters. All eight observations must exist.

Basis: consolidated. Period: 2024-09 to 2026-06.

View the financial table · Data source

Profit and operating cash flow

For Mar 2026, operating cash flow was ₹3,445.00 crore and net profit was ₹1,362.00 crore. Operating cash flow ÷ net profit was 2.53 times.

Calculation and source

These are different accounting measures. The ratio, when shown, uses the same reporting period and accounting basis; it is not an earnings-quality rating.

Basis: consolidated. Period: 2026-03.

View the financial table · Data source

Net profit history

Net profit was positive in 4 of 5 available annual observations in the five-year window ending Mar 2026.

Calculation and source

Count observations greater than zero. Missing years are excluded from both counts. Zero is not counted as positive.

Basis: consolidated. Period: 2022-03 to 2026-03.

View the financial table · Data source

Operating cash flow history

Operating cash flow was positive in 3 of 5 available annual observations in the five-year window ending Mar 2026.

Calculation and source

Count observations greater than zero. Missing years are excluded from both counts. Zero is not counted as positive.

Basis: consolidated. Period: 2022-03 to 2026-03.

View the financial table · Data source

Reported borrowings change

Reported borrowings was ₹594.00 crore in Mar 2026, compared with ₹2,473.00 crore in Mar 2025. The change was a decrease of ₹1,879.00 crore. Year-on-year change: -76.0%.

Calculation and source

Absolute change = later amount − earlier amount. Percentage change = (later ÷ earlier − 1) × 100.

Basis: consolidated. Period: 2025-03 to 2026-03.

View the financial table · Data source

Promoters ownership share

Reported Promoters ownership moved from 46.65% in Mar 2026 to 46.65% in Jun 2026, a change of 0.00 percentage points.

Calculation and source

Later ownership percentage − earlier percentage. Ownership proportions do not establish purchases or sales; changes in share capital can also affect them.

Basis: Issuer ownership; separately refreshed. Period: 2026-03 to 2026-06.

View the financial table · Data source

FIIs ownership share

Reported FIIs ownership moved from 20.35% in Mar 2026 to 20.89% in Jun 2026, a change of +0.54 percentage points.

Calculation and source

Later ownership percentage − earlier percentage. Ownership proportions do not establish purchases or sales; changes in share capital can also affect them.

Basis: Issuer ownership; separately refreshed. Period: 2026-03 to 2026-06.

View the financial table · Data source

DIIs ownership share

Reported DIIs ownership moved from 19.28% in Mar 2026 to 18.60% in Jun 2026, a change of -0.68 percentage points.

Calculation and source

Later ownership percentage − earlier percentage. Ownership proportions do not establish purchases or sales; changes in share capital can also affect them.

Basis: Issuer ownership; separately refreshed. Period: 2026-03 to 2026-06.

View the financial table · Data source

Summary generated: 11 Oct 2026, 02:22 IST. Figures may be rounded, delayed or restated. Comparisons follow the source’s annual and quarterly classifications; changes in reporting duration or accounting policies can limit comparability. Check original filings. No cause for a change is inferred from arithmetic alone.

Stored market and accounting figures

Price record: 8 October 2026, 6:22 pm +05:30. Not a live quote.

MeasureStored figure
Market Cap62,243 Cr.
Current Price2,210
High / Low2,538/1,793
Stock P/E20.0
Book Value372
Dividend Yield0.23 %
ROCE39.8 %
ROE23.6 %
Face Value1.00

Market cap is in ₹ crore; prices and per-share values are in ₹. P/E is a multiple; yield, ROCE and ROE are percentages. Book value is an accounting figure, not an estimate of the share's investment value.

Competitors

Stock Name ⇩Market Cap ⇩Current Price ⇩High / Low ⇩Stock P/E ⇩Book Value ⇩Dividend Yield ⇩ROCE ⇩ROE ⇩Face Value ⇩
Glenmark Life Sciences Ltd 62,243 Cr. 2,210 2,538/1,79320.0 3720.23 %39.8 %23.6 % 1.00
Alkem Laboratories Ltd 63,221 Cr. 5,279 5,934/5,05127.8 1,1561.00 %21.2 %18.9 % 2.00
Glenmark Pharmaceuticals Ltd 64,200 Cr. 2,293 2,538/1,79320.6 3720.22 %39.8 %23.6 % 1.00
Biocon Ltd 57,105 Cr. 349 447/33878.5 2100.14 %3.61 %1.40 % 5.00
Abbott India Ltd 55,143 Cr. 26,000 30,655/25,13534.2 2,2472.02 %44.8 %34.4 % 10.0
Industry Average17,127.26 Cr1,216.6253.25211.240.40%26.16%16.59%6.06

All Competitor Stocks of Glenmark Life Sciences Ltd

FINANCIALS

Quarterly performance

Compare sales, expenses, operating profit and net profit on one chart, across the same reporting quarters.

Sales, expenses & profits

₹ crore

Compare the lines together. Select a metric below to show or hide it.

Chart loads as you scroll. Values are available in the table.

All reported periods
Supporting financial tableAll reported figures · use a chart icon for peer comparison

Quarterly Chart Table

MetricJun 2023Sep 2023Dec 2023Mar 2024Jun 2024Sep 2024Dec 2024Mar 2025Jun 2025Sep 2025Dec 2025Mar 2026Jun 2026
Sales 3,0363,2072,5073,0633,2443,4343,3883,2563,2646,0473,9013,7714,018
Expenses 2,5992,7452,7152,5592,6562,8322,7872,6952,6843,6873,0313,0083,214
Operating Profit 437462-2095045886026005615812,360870763805
OPM % 14%14%-8%16%18%18%18%17%18%39%22%20%20%
Other Income -32-20587351313931-361-297-1,184-140-18466
Interest 112121134149404852675866414354
Depreciation 142141147151118120123125130141154148173
Profit before tax 151-6-403555462473456896967534388643
Tax % -14%997%-18%319%26%25%24%45%51%37%24%22%25%
Net Profit 173-62-331-1,214340354348447610403301483
EPS in Rs 5.31-2.90-12.45-43.1712.0612.5512.330.161.6621.6314.2910.6817.11

Last Updated: September 29, 2026, 6:23 am

FINANCIALS

Annual performance

Compare sales, expenses, operating profit and net profit across financial years. Trailing figures remain in the table.

Sales, expenses & profits

₹ crore

Compare the lines together. Select a metric below to show or hide it.

Chart loads as you scroll. Values are available in the table.

All reported periods

Earnings per share

₹ per share

Hover or tap the chart for dated values.

Chart loads as you scroll. Values are available in the table.

All reported periods
Supporting financial tableAll reported figures · use a chart icon for peer comparison

Profit & Loss Chart Table

Last Updated: September 26, 2026, 10:43 pm

MetricMar 2014Mar 2015Mar 2016Mar 2017Mar 2018Mar 2019Mar 2020Mar 2021Mar 2022Mar 2023Mar 2024Mar 2025Mar 2026TTM
Sales 6,0056,5637,5629,0799,0749,86510,64110,94412,30511,58311,81313,32216,98317,737
Expenses 4,9145,3486,1257,0437,4578,2808,9428,8609,9789,94810,61810,97012,41012,940
Operating Profit 1,0911,2141,4372,0371,6171,5861,6992,0842,3271,6351,1952,3514,5724,797
OPM % 18%18%19%22%18%16%16%19%19%14%10%18%27%27%
Other Income 11-18020-448937519195-101-10336-259-1,805-1,443
Interest 189190179237286335377353298349516207209204
Depreciation 217300234264302326417444487569582486573617
Profit before tax 6975441,0441,4911,1191,3011,0961,3821,4417074341,3991,9852,533
Tax % 22%61%29%26%28%29%29%30%31%47%430%25%31%
Net Profit 5462097431,109804925776970994377-1,4341,0471,3621,798
EPS in Rs 19.997.7226.3339.2928.4932.7827.5034.3833.3710.53-53.2237.1148.2663.71
Dividend Payout % 0%26%8%5%7%6%9%7%7%24%-5%7%10%

YoY Net Profit Growth

Year2014-20152015-20162016-20172017-20182018-20192019-20202020-20212021-20222022-20232023-20242024-20252025-2026
YoY Net Profit Growth (%)-61.72%255.50%49.26%-27.50%15.05%-16.11%25.00%2.47%-62.07%-480.37%173.01%30.09%
Change in YoY Net Profit Growth (%)0.00%317.22%-206.24%-76.76%42.55%-31.16%41.11%-22.53%-64.55%-418.30%653.38%-142.93%

Glenmark Life Sciences Ltd has shown an inconsistent trend in YoY Net Profit Growth (%) in the last 12 years from 2014-2015 to 2025-2026.

Growth

Compounded Sales Growth
10 Years:7%
5 Years:5%
3 Years:3%
TTM:11%
Compounded Profit Growth
10 Years:17%
5 Years:12%
3 Years:6%
TTM:159%
Stock Price CAGR
10 Years:7%
5 Years:33%
3 Years:74%
1 Year:16%
Return on Equity
10 Years:6%
5 Years:-1%
3 Years:-10%
Last Year:16%

Last Updated: September 5, 2025, 3:36 pm

FINANCIALS

Balance sheet

Compare reserves and borrowings across the same financial years. Reserves are an accounting balance, not available cash.

Reserves & borrowings

₹ crore

Compare the lines together. Select a metric below to show or hide it.

Chart loads as you scroll. Values are available in the table.

All reported periods
Supporting financial tableAll reported figures · use a chart icon for peer comparison

Balance Sheet Data Table

Last Updated: August 19, 2026, 6:30 am

MonthMar 2015Mar 2016Mar 2017Mar 2018Mar 2019Mar 2020Mar 2021Mar 2022Mar 2023Mar 2024Mar 2025Mar 2026
Equity Capital 272828282828282828282828
Reserves 1,7563,6014,4645,1355,5776,0427,0369,0589,4467,8208,82110,484
Borrowings 3,8003,9884,7244,6394,4494,8694,9863,9624,6081,2312,473594
Other Liabilities 2,7262,5752,5482,7933,2353,7293,5244,0035,2895,2794,6698,801
Total Liabilities 8,30910,19311,76412,59513,28914,66815,57517,05219,37114,35815,99119,907
Fixed Assets 2,0152,5942,7553,0303,6705,0295,1295,8875,4224,2104,4875,915
CWIP 4775437081,1221,3991,2221,3821,0101,190662835909
Investments 1717161530252550457905642
Other Assets 5,7997,0398,2858,4298,1908,3939,04010,10512,7158,69710,61313,041
Total Assets 8,30910,19311,76412,59513,28914,66815,57517,05219,37114,35815,99119,907
FINANCIALS

Cash generation

Compare operating cash and free cash flow across reported periods. Negative values remain visible.

Operating & free cash flow

₹ crore

Compare the lines together. Select a metric below to show or hide it.

Chart loads as you scroll. Values are available in the table.

All reported periods
Supporting financial tableAll reported figures · use a chart icon for peer comparison

Cash Flows

MonthMar 2015Mar 2016Mar 2017Mar 2018Mar 2019Mar 2020Mar 2021Mar 2022Mar 2023Mar 2024Mar 2025Mar 2026
Cash from Operating Activity + 4823456571,6481,3241,3921,1311,109625-265-8283,445
Cash from Investing Activity + -712-950-1,001-1,003-883-774-662-316-5154,38758-1,237
Cash from Financing Activity + 199699543-468-739-445-442-520-77-3,906787-2,709
Net Cash Flow -3193199177-297174282723221517-501
Free Cash Flow -56-544-7662571261645632075-1,162-1,5762,090
CFO/OP 66%57%67%124%111%109%79%72%77%65%-6%92%
Free cash flowAll reported figures · use a chart icon for peer comparison

Free Cash Flow Table

Free cash flow reported in the stored cash-flow statement (₹ Cr)
PeriodMar 2015Mar 2016Mar 2017Mar 2018Mar 2019Mar 2020Mar 2021Mar 2022Mar 2023Mar 2024Mar 2025Mar 2026
Free Cash Flow-56.00-544.00-76.00625.00712.00616.00456.00320.0075.00-1,162.00-1,576.002,090.00

This table and the chart use the Free Cash Flow row from the same stored cash-flow statement. Free cash flow generally measures operating cash flow after capital expenditure; check the source definition and reporting basis. It is not operating profit minus borrowings.

Financial efficiency feed. Source: www.screener.in. The source URL identifies consolidated accounts. Values from separate feeds can differ, even for the same period; they are not interchangeable. Use each table’s period labels. Data methodology.

FINANCIALS

Financial & business efficiency

Compare collection, inventory, payment and working-capital cycles together in days. Returns on capital and equity follow in a separate percentage chart.

Working capital

Days

Compare the lines together. Select a metric below to show or hide it.

Chart loads as you scroll. Values are available in the table.

All reported periods

Returns on capital & equity

%

Hover or tap the chart for dated values.

Chart loads as you scroll. Values are available in the table.

All reported periods
Supporting financial tableAll reported figures · use a chart icon for peer comparison

Financial Efficiency Data Table

MonthMar 2014Mar 2015Mar 2016Mar 2017Mar 2018Mar 2019Mar 2020Mar 2021Mar 2022Mar 2023Mar 2024Mar 2025
Debtor Days 1311401209794818386921155792
Inventory Days 191247249299244244211230208203208254
Days Payable 279379308243225241210226190172210216
Cash Conversion Cycle 4386115211385849011014756129
Working Capital Days 6247511259964546765141-244
ROCE %15%16%19%21%15%15%14%15%16%10%12%19%
FINANCIALS

Ownership trends

Compare ownership groups across the same reporting dates. Shareholder counts appear separately below.

Shareholding comparison

%

Compare the lines together. Select a metric below to show or hide it.

Chart loads as you scroll. Values are available in the table.

All reported periods

Shareholder count

Shareholders

Hover or tap the chart for dated values.

Chart loads as you scroll. Values are available in the table.

All reported periods
Supporting financial tableAll reported figures · use a chart icon for peer comparison

Shareholding Pattern

MonthSep 2023Dec 2023Mar 2024Jun 2024Sep 2024Dec 2024Mar 2025Jun 2025Sep 2025Dec 2025Mar 2026Jun 2026
Promoters 46.65%46.65%46.65%46.65%46.65%46.65%46.65%46.64%46.64%46.65%46.65%46.65%
FIIs 24.79%23.71%21.38%20.98%23.05%23.51%23.15%20.62%20.73%19.20%20.35%20.89%
DIIs 10.31%10.92%13.36%13.93%13.21%13.85%14.60%17.64%18.61%20.09%19.28%18.60%
Government 0.04%0.04%0.04%0.04%0.04%0.04%0.04%0.04%0.04%0.04%0.04%0.04%
Public 18.21%18.70%18.58%18.42%17.06%15.96%15.56%15.05%13.97%14.02%13.70%13.81%
No. of Shareholders 2,32,6852,09,9311,99,4511,92,6301,93,9491,95,0591,92,7241,90,2101,98,7892,01,5841,96,1052,11,418
Mutual fund holdingsReported fund ownership · Expand table

Mutual Fund Holdings Data Table

Fund NameNo of SharesAUM (%)Amount Invested (Cr)Previous Number of SharesPrevious DatePercentage Change
Invesco India Midcap Fund 1,864,031 3.81 448.54N/AN/AN/A
Invesco India Contra Fund 1,701,870 2.11 409.521,850,0882026-06-11 19:45:23-8.01%
Invesco India Large & Mid Cap Fund 1,342,939 3.31 323.151,205,1072025-11-03 01:08:2111.44%
Bandhan Small Cap Fund 922,877 0.88 222.07952,8772026-06-11 14:16:05-3.15%
Mirae Asset Healthcare Fund 869,397 7.12 209.2922,5432026-06-11 08:22:47-5.76%
Bandhan Large & Mid Cap Fund 864,165 1.25 207.94749,1652026-03-23 17:45:0215.35%
Axis Midcap Fund 710,280 0.53 170.911,361,0252025-12-15 01:33:05-47.81%
Tata Mid Cap Fund 600,000 2.58 144.38N/AN/AN/A
Tata Arbitrage Fund 497,625 0.55 119.74859,5002026-01-26 05:12:19-42.1%
Edelweiss Balanced Advantage Fund 496,818 0.93 119.55N/AN/AN/A

Alternate ratio feed. Source: www.way2wealth.com. The accounting basis and ratio definitions require verification against the source. Values from separate feeds can differ, even for the same period; they are not interchangeable. Use each table’s period labels. Data methodology.

FINANCIALS

Ratios from the alternate data feed

Related measures share a chart and a common unit. Use the dated figures below to examine any change.

Profitability ratios

%

Compare the lines together. Select a metric below to show or hide it.

Chart loads as you scroll. Values are available in the table.

All reported periods

Liquidity ratios

Multiple (×)

Compare the lines together. Select a metric below to show or hide it.

Chart loads as you scroll. Values are available in the table.

All reported periods

Distributions & retention

%

Compare the lines together. Select a metric below to show or hide it.

Chart loads as you scroll. Values are available in the table.

All reported periods

Interest coverage

Multiple (×)

Compare the lines together. Select a metric below to show or hide it.

Chart loads as you scroll. Values are available in the table.

All reported periods

Valuation multiples

Multiple (×)

Compare the lines together. Select a metric below to show or hide it.

Chart loads as you scroll. Values are available in the table.

All reported periods
Supporting financial tableAll reported figures · use a chart icon for peer comparison

Key Financial Ratios

MonthMar 25Mar 24Mar 23Mar 22Mar 21
FaceValue 1.001.001.001.001.00
Basic EPS (Rs.) 37.11-53.2210.5333.3734.38
Diluted EPS (Rs.) 37.11-53.2210.5333.3734.38
Cash EPS (Rs.) 54.33-30.1835.0452.4650.10
Book Value[Excl.RevalReserv]/Share (Rs.) 313.60278.09348.70334.48250.36
Book Value[Incl.RevalReserv]/Share (Rs.) 313.60278.09348.70334.48250.36
Revenue From Operations / Share (Rs.) 472.08418.62460.36436.08387.85
PBDIT / Share (Rs.) 87.3672.1391.9788.1475.65
PBIT / Share (Rs.) 70.1351.5070.3170.8959.93
PBT / Share (Rs.) 49.581.2930.7851.0848.99
Net Profit / Share (Rs.) 37.11-50.8013.3735.2134.38
NP After MI And SOA / Share (Rs.) 37.11-53.2110.5333.3734.38
PBDIT Margin (%) 18.5017.2219.9720.2119.50
PBIT Margin (%) 14.8512.3015.2716.2515.45
PBT Margin (%) 10.500.306.6811.7112.63
Net Profit Margin (%) 7.86-12.132.908.078.86
NP After MI And SOA Margin (%) 7.86-12.712.287.658.86
Return on Networth / Equity (%) 11.83-19.133.1310.3613.73
Return on Capital Employeed (%) 19.6217.0113.8416.1314.83
Return On Assets (%) 6.52-10.451.535.516.21
Long Term Debt / Equity (X) 0.050.000.400.280.55
Total Debt / Equity (X) 0.240.120.450.400.66
Asset Turnover Ratio (%) 0.870.700.710.420.42
Current Ratio (X) 1.561.281.961.771.75
Quick Ratio (X) 1.050.841.371.231.21
Inventory Turnover Ratio (X) 4.811.151.311.851.85
Dividend Payout Ratio (NP) (%) 6.73-4.6923.737.497.27
Dividend Payout Ratio (CP) (%) 4.60-7.667.764.934.99
Earning Retention Ratio (%) 93.27104.6976.2792.5192.73
Cash Earning Retention Ratio (%) 95.40107.6692.2495.0795.01
Interest Coverage Ratio (X) 11.903.947.428.346.04
Interest Coverage Ratio (Post Tax) (X) 7.86-0.804.275.213.62
Enterprise Value (Cr.) 43947.2726350.4516364.2715087.8616656.12
EV / Net Operating Revenue (X) 3.302.231.261.231.52
EV / EBITDA (X) 17.8312.956.316.077.80
MarketCap / Net Operating Revenue (X) 3.262.291.011.011.20
Retention Ratios (%) 93.26104.6976.2692.5092.72
Price / BV (X) 4.913.441.381.371.86
Price / Net Operating Revenue (X) 3.262.291.011.011.20
EarningsYield 0.02-0.050.020.070.07
Advertisements
Explore Industry-wise Company financial data